SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-035624
Filing Date
2020-02-13
Accepted
2020-02-13 16:29:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d876642dsc13g.htm SC 13G 38432
  Complete submission text file 0001193125-20-035624.txt   40189
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filed by) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Subject) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91049 | Film No.: 20611077
SIC: 2836 Biological Products, (No Diagnostic Substances)